Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now Frankfurt - Delayed Quote • EUR Xvivo Perfusion AB (publ) (3XV.F) Follow Compare 25.30 +0.92 +(3.77%) As of 10:52:19 AM GMT+2. Market Open. Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for 3XV.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: 3XV.F View More All News Press Releases SEC Filings Conference Call on Interim Report January-March 2025 Annual Report 2024 Notice to Attend the Annual General Meeting in XVIVO Perfusion AB (publ) European Stocks Estimated To Be Trading Below Fair Value In March 2025 Year-End Report 2024 Conference Call on Year-End Report 2024 Xvivo Perfusion And 2 More Stocks Estimated To Be Trading Below Their Intrinsic Value Enrollment Completed Five Months Early in the US Clinical Trial Evaluating XVIVOs Heart Preservation Technology 3 Undervalued Small Caps With Insider Buying Across Regions XVIVO Perfusion Appoints Lena Hagman as Deputy CEO 3 Stocks Estimated To Be Trading Up To 42.3% Below Intrinsic Value